000149840 001__ 149840
000149840 005__ 20251017144549.0
000149840 0247_ $$2doi$$a10.1080/09513590.2018.1472761
000149840 0248_ $$2sideral$$a109777
000149840 037__ $$aART-2018-109777
000149840 041__ $$aeng
000149840 100__ $$aMartínez-Domínguez, S.J.
000149840 245__ $$aSystematic review and meta-analysis of Spanish studies regarding the association between maternal 25-hydroxyvitamin D levels and perinatal outcomes
000149840 260__ $$c2018
000149840 5060_ $$aAccess copy available to the general public$$fUnrestricted
000149840 5203_ $$aObjective: This systematic review and meta-analysis of Spanish studies assessed the association of maternal 25-hydroxyvitamin D [25(OH)D] levels on perinatal outcomes. Methods: PubMed, Cochrane Library, Embase, Scielo, Scopus, and Web of Science research databases were searched from inception through December 30 2017 using the terms ‘vitamin D’, ‘pregnancy’, and ‘Spain’. Studies that compared first or second half of pregnancy normal 25(OH)D (=30.0 ng/mL) versus insufficient (20.0–29.9 ng/mL) or deficient (<20.0 ng/mL) circulating levels and perinatal outcomes were systematically extracted. Data are presented as pooled odds ratios and their 95% confidence intervals (CIs) for categorical variables or mean differences and CIs for continuous variables. Risk of bias was evaluated with the Newcastle–Ottawa Scale. Results: Five cohort studies met inclusion criteria. The risk of gestational diabetes mellitus, preeclampsia, preterm birth, and small-for-gestational-age infants, and birthweight was not influenced by first half of pregnancy maternal 25(OH)D levels. In addition, second half of pregnancy 25(OH) levels did not affect birthweight. Conclusion: Maternal 25(OH)D levels during pregnancy did not affect studied perinatal outcomes and birthweight.
000149840 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc-nd$$uhttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
000149840 590__ $$a1.406$$b2018
000149840 591__ $$aOBSTETRICS & GYNECOLOGY$$b63 / 82 = 0.768$$c2018$$dQ4$$eT3
000149840 591__ $$aENDOCRINOLOGY & METABOLISM$$b129 / 145 = 0.89$$c2018$$dQ4$$eT3
000149840 592__ $$a0.599$$b2018
000149840 593__ $$aEndocrinology$$c2018$$dQ2
000149840 593__ $$aObstetrics and Gynecology$$c2018$$dQ2
000149840 593__ $$aEndocrinology, Diabetes and Metabolism$$c2018$$dQ2
000149840 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000149840 700__ $$0(orcid)0000-0003-4720-8231$$aTajada, M.$$uUniversidad de Zaragoza
000149840 700__ $$aChedraui, P.
000149840 700__ $$0(orcid)0000-0002-2801-416X$$aPérez-López, F.R.$$uUniversidad de Zaragoza
000149840 7102_ $$11004$$2645$$aUniversidad de Zaragoza$$bDpto. Cirugía,Ginecol.Obstetr.$$cÁrea Obstetricia y Ginecología
000149840 773__ $$g34, 11 (2018), 987-994$$pGynecol. endocrinol.$$tGYNECOLOGICAL ENDOCRINOLOGY$$x0951-3590
000149840 8564_ $$s2321617$$uhttps://zaguan.unizar.es/record/149840/files/texto_completo.pdf$$yVersión publicada
000149840 8564_ $$s1144571$$uhttps://zaguan.unizar.es/record/149840/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000149840 909CO $$ooai:zaguan.unizar.es:149840$$particulos$$pdriver
000149840 951__ $$a2025-10-17-14:11:14
000149840 980__ $$aARTICLE